Modelling the cascade of biomarker changes in <i>GRN</i>-related frontotemporal dementia.

Abstract

Progranulin-related frontotemporal dementia (FTD-<i>GRN</i>) is a fast progressive disease. Modelling the cascade of multimodal biomarker changes aids in understanding the aetiology of this disease and enables monitoring of individual mutation carriers. In this cross-sectional study, we estimated the temporal cascade of biomarker changes for FTD-<i>GRN</i>, in a data-driven way. We included 56 presymptomatic and 35 symptomatic <i>GRN</i> mutation carriers, and 35 healthy non-carriers. Selected biomarkers were neurofilament light chain (NfL), grey matter volume, white matter microstructure and cognitive domains. We used discriminative event-based modelling to infer the cascade of biomarker changes in FTD-<i>GRN</i> and estimated individual disease severity through cross-validation. We derived the biomarker cascades in non-fluent variant primary progressive aphasia (nfvPPA) and behavioural variant FTD (bvFTD) to understand the differences between these phenotypes. Language functioning and NfL were the earliest abnormal biomarkers in FTD-<i>GRN</i>. White matter tracts were affected before grey matter volume, and the left hemisphere degenerated before the right. Based on individual disease severities, presymptomatic carriers could be delineated from symptomatic carriers with a sensitivity of 100% and specificity of 96.1%. The estimated disease severity strongly correlated with functional severity in nfvPPA, but not in bvFTD. In addition, the biomarker cascade in bvFTD showed more uncertainty than nfvPPA. Degeneration of axons and language deficits are indicated to be the earliest biomarkers in FTD-<i>GRN</i>, with bvFTD being more heterogeneous in disease progression than nfvPPA. Our data-driven model could help identify presymptomatic <i>GRN</i> mutation carriers at risk of conversion to the clinical stage.